Afternoon Report / Market sold hard into the close (ORI, APX, WES, IPL)

By Market Matters 12 March 19

Market sold hard into the close (ORI, APX, WES, IPL)

Market Matters Afternoon Report 12th March


The market held up pretty well for most of the session and was actually up +42 points at the high,  however in the last hour of trade there was a big seller of stocks out there – most large caps finished on their lows with the market dropping -11 points in the match after falling around 25 points from 3pm onwards. The large caps felt the brunt – futures led selling by the look – or a large portfolio exiting. Asian markets were actually strong while US Futures were in the  green all day however it seemed to be Aussie focussed selling that really kicked in late in the day. When that sort of sell off happens, it tends to last a few days  so we could be in for a period of underperformance, giving back some of the recent outperformance.

Energy bounced back today after yesterday’s sell off -  Beach Energy (BPT) the best of them adding +3% while Appen (APX) dropped by 9% after coming back on stream following a capital raise – the retail component still to complete which we cover below. Elsewhere, those stocks exposed to the UK rallied, Janus (JHG) up +4.19% and CYBG (CYB) added +3.03% on positive developments around BREXIT  - although still come way to go  it would seem. They vote tomorrow, then the next day and the one after that on various parts to the deal – more to come here and those stocks will likely stay in focus.

Overall today, the ASX 200 lost -5 points or -0.09% to 6174. Dow Futures are currently trading up +68pts / +0.27%.

ASX 200 Chart

ASX 200 Chart


Mortgage Brokers; In a backflip from the Government, they’ve reversed a decision to ban trail commissions for mortgage brokers, as proposed by the royal commission – they now say it’s a bad idea. Good news for Mortgage Choice (MOC) which put on +12% today although it’s been a tough year for them…

Mortgage (MOC) Chart

Appen (APX) -9.15% today  after successfully raising $285m via an institutional placement at $21.50 per share for the US acquisition we discussed yesterday. New shares are expected to settle with institutions on the 15th March making them tradable on Monday 18th March. The company also launched a retail offer via a Share Purchase Plan (SPP) for existing shareholders in the company. Shareholders had to be on the register on Friday 8th March 2019. Under the offer, each retail shareholder can apply for up to $15,000 worth of new shares at $21.50, or if the Appen share price is trading below $21.50, shares will be allotted at a price that reflects a 2% discount to the volume weighted average price up to and including the closing date of the SPP. As an example, if we assume APX’s share price on a volume weighted basis is $21.00 over the 5 days of the offer, new shares will be issued at $20.58. The SPP document is yet to be issued (due out 20th March).

Appen (APX) Chart

The mining chemicals & explosives stock we own in the Platinum Portfolio, Orica (ORI), bucked the index weakness and traded higher today, closing +1.68%. The explosives space has long been the subject of consolidation whispers and news articles today suggest we are getting closer to a deal. The Australian reported that private equity firms such Brookfield, BGH & Bain Capital have been keen watchers of the space, consisting of two major ASX listed stocks in Incitec Pivot (IPL) and Orica.

Another player expected to join the fun is Wesfarmers (WES). Rob Scott, who was shuffled into the CEO role early in 2017, has been divesting assets out of the Wesfarmers in an effort to ‘shrink to grow,’ culminating in the demerger of Coles (COL) late last year. Now a cashed up Wesfarmer’s will be eyeing bolt on opportunities to add to its existing businesses.  Prior to becoming the CEO, Rob was the head of the Wesfarmer’s industrials division and he has previously earmarked this as an area for growth. Still though, a deal is not done, and some obvious issues to make those on the offensive nervous. Orica has suffered some operational issues at its new Burrup plant in WA, the worst of which saw the operation out of action for a whole month in the middle of last year. We like Orica, with or without a takeover bid.

Orica (ORI) Chart

Broker Moves

·         Qube Upgraded to Buy at Goldman; PT A$3.12

·         Appen Upgraded to Buy at Citi; PT A$28.04

·         Coles Group Upgraded to Buy at Morningstar

·         Perpetual Downgraded to Sell at Morningstar

·         InvoCare Upgraded to Buy at Morningstar

·         Chorus Rated New Buy at New Street Research; PT NZ$6.80

·         ANZ Bank Downgraded to Neutral at Credit Suisse; PT A$28

·         Star Entertainment Raised to Outperform at Credit Suisse

·         Charter Hall Education T Cut to Neutral at Goldman; PT A$3.31


No changes today

Have a great night

James / Harry & the Market Matters Team


Market Matters may hold stocks mentioned in this report. Subscribers can view a full list of holdings on the website by clicking here. Positions are updated each Friday, or after the session when positions are traded.


All figures contained from sources believed to be accurate.  Market Matters does not make any representation of warranty as to the accuracy of the figures and disclaims any liability resulting from any inaccuracy.  Prices as at 12/03/2019

Reports and other documents published on this website and email (‘Reports’) are authored by Market Matters and the reports represent the views of Market Matters. The MarketMatters Report is based on technical analysis of companies, commodities and the market in general. Technical analysis focuses on interpreting charts and other data to determine what the market sentiment about a particular financial product is, or will be. Unlike fundamental analysis, it does not involve a detailed review of the company’s financial position.

The Reports contain general, as opposed to personal, advice. That means they are prepared for multiple distributions without consideration of your investment objectives, financial situation and needs (‘Personal Circumstances’). Accordingly, any advice given is not a recommendation that a particular course of action is suitable for you and the advice is therefore not to be acted on as investment advice. You must assess whether or not any advice is appropriate for your Personal Circumstances before making any investment decisions. You can either make this assessment yourself, or if you require a personal recommendation, you can seek the assistance of a financial advisor.  Market Matters or its author(s) accepts no responsibility for any losses or damages resulting from decisions made from or because of information within this publication. Investing and trading in financial products are always risky, so you should do your own research before buying or selling a financial product.

The Reports are published by Market Matters in good faith based on the facts known to it at the time of their preparation and do not purport to contain all relevant information with respect to the financial products to which they relate. Although the Reports are based on information obtained from sources believed to be reliable, Market Matters does not make any representation or warranty that they are accurate, complete or up to date and Market Matters accepts no obligation to correct or update the information or opinions in the Reports. Market Matters may publish content sourced from external content providers.

If you rely on a Report, you do so at your own risk. Past performance is not an indication of future performance. Any projections are estimates only and may not be realised in the future. Except to the extent that liability under any law cannot be excluded, Market Matters disclaims liability for all loss or damage arising as a result of any opinion, advice, recommendation, representation or information expressly or impliedly published in or in relation to this report notwithstanding any error or omission including negligence.